Aylin Kont Ozhan
Overview
Explore the profile of Aylin Kont Ozhan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
4
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Selmanoglu A, Haci I, Koc F, Kavas Yildiz Y, Arik Yilmaz E, Azkur D, et al.
Pediatr Res
. 2024 Nov;
PMID: 39558120
Background: Diagnosing anaphylaxis in children within the first 2 years of life can be difficult due to the often confusing and nonspecific signs and symptoms. Objective: This study focuses on...
2.
Arikoglu T, Tokmeci N, Demirhan A, Ozhan A, Yalaki A, Akbey V, et al.
Int J Clin Pharm
. 2024 Jun;
46(6):1294-1306.
PMID: 38861048
Background: Arylpropionic acid derivatives (APs) are the main triggers of nonsteroidal anti-inflammatory drug (NSAID) hypersensitivity. Data on clinical patterns and risk factors for AP hypersensitivity in children are quite limited....
3.
Ozhan A, Arikoglu T, Er M, Unal S, Yildirim D, Erkasar F, et al.
Medicina (Kaunas)
. 2024 Mar;
60(3).
PMID: 38541172
: Data on characteristics of asthma in children with sickle cell disease (SCD) is conflicting. Recently, the L-arginine pathway has gained attention in the pathogenesis of asthma and SCD. This...
4.
Ozerturk S, Yildirim D, Arikoglu T, Kuyucu S, Ozhan A
Pediatr Allergy Immunol Pulmonol
. 2024 Mar;
37(1):22-32.
PMID: 38484271
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare potentially life-threatening hypersensitivity disorders characterized by widespread skin and mucosal involvement. However, there is no standardized evidence-based treatment to reduce...
5.
Ozhan A, Arikoglu T
Children (Basel)
. 2024 Jan;
11(1).
PMID: 38255399
Pediatric data on the clinical and etiologic features, treatment response, and use of omalizumab for chronic urticaria (CU) are quite limited. The aim of this study was to evaluate the...
6.
Ozhan A, Demirhan A, Arikoglu T, Karahan F, Gokalp Satici F, Tokmeci N, et al.
Dermatitis
. 2024 Jan;
35(3):275-287.
PMID: 38165639
Chemotherapeutic drugs can lead to a wide spectrum of cutaneous findings, ranging from nonimmune toxic reactions to severe immune-mediated hypersensitivity reactions. The aim of this study was to evaluate the...
7.
Arikoglu T, Tokmeci N, Demirhan A, Ozhan A, Yalaki A, Akbey V, et al.
Allergy Asthma Proc
. 2023 Dec;
45(1):14-23.
PMID: 38151729
Different recommendations for the classification of nonsteroidal anti-inflammatory drug hypersensitivity reactions (NSHSR) in children have been reported but a shortage still exists. The aim of the present study was to...
8.
Arikoglu T, Ozhan A, Kuyucu S
Curr Pharm Des
. 2022 Oct;
29(3):209-223.
PMID: 36281867
Although an increase in the incidence of childhood anaphylaxis has been reported, it remains underdiagnosed. Foods are the most common triggers for anaphylaxis, particularly cow's milk, hen's egg, and nuts....
9.
Agin M, Bisgin A, Yilmaz M, Ozhan A, Mammadov F, Tumgor G
J Pak Med Assoc
. 2021 Apr;
71(2(A)):479-483.
PMID: 33819232
Objective: To determine the cumulative effects of Mediterranean fever gene polymorphisms and mutations in patients with ınflammatory bowel diseases. Methods: The case-control study was conducted from January, 2012, to January,...